Credit Suisse downgraded Lupin from ‘outperform’ to ‘neutral’ rating and upped the price target from Rs 710 earlier to Rs 755.

Lupin has launched generic version of Tricor in the US market after getting approval from the US Food and Drug Administration.

The US health regulator has granted approval to Lupin to market generic Fenofibrate Tablets, a cholesterol lowering drug, in the American m...